Bank of New York Mellon
HPTX

Bank of New York Mellon’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Bank of New York Mellon’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-65,330
Closed -$3M – 4395
2015
Q1 		$3M Sell
65,330
-4,817
-7% -$144K ﹤0.01% 2605
2014
Q4 		$1.68M Buy
70,147
+3,466
+5% +$78.1K ﹤0.01% 2979
2014
Q3 		$1.68M Buy
66,681
+16,342
+32% +$406K ﹤0.01% 3003
2014
Q2 		$1.31M Buy
50,339
+11,066
+28% +$284K ﹤0.01% 3152
2014
Q1 		$1.01M Buy
39,273
+3,606
+10% +$97.7K ﹤0.01% 3271
2013
Q4 		$721K Buy
35,667
+5,756
+19% +$135K ﹤0.01% 3449
2013
Q3 		$782K Sell
29,911
-169
-0.6% -$4.23K ﹤0.01% 3368
2013
Q2 		$662K Buy
+30,080
New +$659K ﹤0.01% 3390

Bank of New York Mellon's HPTX Position: Q2 2015 in Review

Bank of New York Mellon sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 65,330 shares — an estimated $3M sold.

Bank of New York Mellon first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $3M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Bank of New York Mellon reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Bank of New York Mellon sold 65,330 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $3M.
  • Bank of New York Mellon first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Bank of New York Mellon's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $3M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Bank of New York Mellon's 13F filing for Q2 2015, filed 6 Aug 2015.